Literature DB >> 8713793

Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G.

K Kolev1, E Komorowicz, W G Owen, R Machovich.   

Abstract

The relative contribution of plasmin, miniplasmin, PMN-elastase and cathepsin G to the fibrin-gel dissolution is studied. The global kcat/KM ratios are determined as a measure of the fibrinolytic catalytic efficiency using spectrophotometric kinetic analysis of the competition between fibrin and synthetic peptide substrates for the proteases, turbidimetric assay for fibrin dissolution and gel-filtration of the partially degraded fibrin. When the substrate is fibrin polymerized in the presence of 3 mM Ca2+, the value of this ratio is 4.3 x 10(5) M-1.s-1 for plasmin, 1.9 x 10(5) M-1.s-1 for miniplasmin, 5.0 x 10(4) M-1.s-1 for PMN-elastase and 2.2 x 10(3) M-1.s-1 for cathepsin G. When fibrin is polymerized without addition of Ca2+, the kcat/KM values are increased by a factor of 2.3 for plasmin, 2.0 for miniplasmin and 1.6 for cathepsin G, whereas that of PMN-elastase is unchanged. Progressive cross-linking of fibrin decreases the catalytic action of all studied proteases, but no change in their relative contribution to fibrinolysis is observed. When plasmin inhibitor (at physiological concentration) is also cross-linked to fibrin, the most efficient fibrinolytic enzymes are miniplasmin and PMN-elastase. The effect of 6-aminohexanoate on the formation of fibrin degradation products by plasmin and miniplasmin suggests that the high-affinity lysine binding site in the N-terminal kringle domain of plasmin is involved in the interactions with the native polymerized fibrin, whereas the fifth kringle found in both enzymes participates in binding to newly exposed lysine residues. These results provide a quantitative basis for the evaluation of fibrinolytic efficiency and support the concept of synergistic fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713793

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  10 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Proteolytic resistance conferred to fibrinogen by von Willebrand factor.

Authors:  A Tanka-Salamon; K Kolev; R Machovich; E Komorowicz
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

3.  Contribution of neutrophil elastase to the lysis of obliterative thrombi in the context of their platelet and fibrin content.

Authors:  Gyöngyi Rábai; Nóra Szilágyi; Péter Sótonyi; Ilona Kovalszky; László Szabó; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2010-08       Impact factor: 3.944

4.  Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets.

Authors:  O A Hamad; K N Ekdahl; P H Nilsson; J Andersson; P Magotti; J D Lambris; B Nilsson
Journal:  J Thromb Haemost       Date:  2008-05-22       Impact factor: 5.824

5.  Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis.

Authors:  E F Kamper; L T Kopeikina; P Trontzas; N C Kyriazis; G Vaiopoulos; J Stavridis
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 6.  Fibrinolytic Enzymes for Thrombolytic Therapy.

Authors:  Swaroop S Kumar; Abdulhameed Sabu
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

7.  Modulation of the von Willebrand factor-dependent platelet adhesion through alternative proteolytic pathways.

Authors:  Nikolett Wohner; András Kovács; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2011-12-15       Impact factor: 3.944

8.  Fibrinolysis in a lipid environment: modulation through release of free fatty acids.

Authors:  G Rábai; B Váradi; C Longstaff; P Sótonyi; V Kristóf; F Timár; R Machovich; K Kolev
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

9.  Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.

Authors:  András Kovács; László Szabó; Colin Longstaff; Kiril Tenekedjiev; Raymund Machovich; Krasimir Kolev
Journal:  Thromb Res       Date:  2013-09-21       Impact factor: 3.944

10.  Increased urokinase and consumption of α2 -antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay.

Authors:  C Longstaff; M Locke
Journal:  J Thromb Haemost       Date:  2018-12-13       Impact factor: 5.824

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.